Professor Max Reynolds
Inventor
Professor Reynolds has over 55 years experience working in a broad range of industries and laboratory facilities around the world. He has been involved in research and production projects and his hands on experience and determination to explore new, practical uses for biotechnology advances places him in a unique position to pursue his personal vision and help NeuMedix Health Group bring new technology to those who need it.
Professor Reynolds invented MAC/MegaBac, a powerful anti-bacterial and viral medication and this invention is the key to some exciting new projects for the NeuMedix Health Group. His role in the management team is to evaluate new scientific and technical opportunities and oversee their progress from research to clinical trials and eventually products available for use in the marketplace.
Professor Reynolds is currently directing clinical trials and research projects in Indonesia, USA, Taiwan, China, Australia and Vietnam covering diseases such as Tuberculosis, Dengue Fever, Avian Influenza (Bird Flu), Anti biotic resistant Helobacter Pylori (duodenal ulcers and stomach cancer) and Cancer research at Griffith and Peking Universities.
He donates his time as a Professor at the Griffith University as Director of the Program for Australian Botanical Medicine for Population Health | 
